March 12, 2026 06:55 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
America’s flip-flop on Russian oil: How Washington sends conflicting signals to India | Big diplomatic win! Iran allows Indian oil tankers through the Strait of Hormuz | ‘It was over in the first hour’: Trump declares victory in Iran war, says ‘nothing left to target’ | Indian-origin shopkeepers face targeted attacks in Wembley; Somali men suspected | Iran pulls out of 2026 FIFA World Cup amid war with US-Israel | Supreme Court allows first-ever passive euthanasia for 32-year-old man in coma for 13 years | As Iran-US war disrupts global gas supply, India issues guidelines to manage shortages | LPG crisis hits metros: Commercial cylinder shortage triggers panic as govt prioritises domestic supply | Iran war disrupts LPG supplies, restaurants in major Indian cities edge towards shutdown | ‘How dare you question judicial officers?’: SC raps Bengal SIR pleas, orders appellate tribunals for voter list appeals

Dr Reddy's launches advanced B2B Customer Service Portal 'XCEED'

| @indiablooms | Mar 18, 2019, at 03:28 pm

Hyderabad, Mar 18 (UNI) Dr Reddy’s Laboratories Limited on Monday announced the launch of its advanced B2B Customer Service Portal “XCEED.”

Fully focused on meeting the growing demand for Dr Reddy’s portfolio of generic Active Pharmaceutical Ingredients (APIs), the customer service portal significantly increases the operational efficiency in doing business with Dr Reddy’s, a company statement here said.

The no-boundaries platform designed based on customers’ insights and feedback, is a huge step forward in providing an advanced customer experience and facilitating collaboration.

Customers are now able to manage the whole business process in real time, from ordering samples to submit and track their orders, but also to closely interact with Dr Reddy’s inter-disciplinary support team and much more. Catering to leading innovator and generic companies across the US., Europe, Latin America, Japan, Korea and other emerging markets, Dr. Reddy’s is recognized as one of the largest API suppliers.

The launch of XCEED gives now instant access to an industry leading portfolio which spans across a wide range of indications and complex molecules such as steroids, peptides or highly potent APIs (HPAPI).

The platform will be presented for the first time to customers during DCAT week in New York from March 18-21, 2019 and will be available to API customers across the globe during the next week, the statement added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm